Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) FCF Margin (2018 - 2025)

Historic FCF Margin for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to 43.38%.

  • Dna X's FCF Margin fell 396900.0% to 43.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 44.05%, marking a year-over-year decrease of 360400.0%. This contributed to the annual value of 14.92% for FY2024, which is 105600.0% down from last year.
  • Dna X's FCF Margin amounted to 43.38% in Q3 2025, which was down 396900.0% from 43.63% recorded in Q2 2025.
  • Dna X's 5-year FCF Margin high stood at 6.37% for Q2 2022, and its period low was 110.41% during Q4 2021.
  • In the last 5 years, Dna X's FCF Margin had a median value of 29.79% in 2024 and averaged 29.45%.
  • In the last 5 years, Dna X's FCF Margin plummeted by -804400bps in 2021 and then skyrocketed by 1011900bps in 2022.
  • Over the past 5 years, Dna X's FCF Margin (Quarter) stood at 110.41% in 2021, then skyrocketed by 92bps to 9.23% in 2022, then soared by 71bps to 2.7% in 2023, then tumbled by -1015bps to 30.15% in 2024, then tumbled by -44bps to 43.38% in 2025.
  • Its last three reported values are 43.38% in Q3 2025, 43.63% for Q2 2025, and 57.45% during Q1 2025.